Sunday, November 01, 2020 5:44:20 AM
The DPLS Squeeze Trigger price of $0.01
is the volume weighted average price
that all Shorts are short
in shares of DPLS
I'll Alert you of stocks to Buy,
before the Run happens !
______________________________________________________________
The possibility of a "Short Squeeze"
Short Squeeze - What it is:
A short squeeze
occurs when the stock's price doesn't decline as anticipated.
A short squeeze is a situation in which
a stock's price increase
triggers a rush of buying activity among short sellers.
Short sellers must buy stock
to close out their short positions and cut their losses,
which results in a further increase in stock prices,
which compel still more short sellers to cover their positions.
The possibility of a "short squeeze"
is one reason some analysts
look at a high amount of short interest
as a Bullish Indicator.
Short Interest is the fuel,
performance is the fuse,
says ShortSqueeze.com
- USA Today
http://shortsqueeze.com/?symbol=DPLS&submit=Short+Quote%E2%84%A2
http://www.investinganswers.com/financial-dictionary/real-estate/short-squeeze-2045
________________________________________________________________
The primary Squeeze Trigger Price,
is the price that
a short squeeze can start in any stock.
There are over 750,000,000 shares that
have been shorted
at the volume weighted average
Squeeze Trigger Price of $0.01
From 2-Years prior
through October 2020,
an aggregate amount of
over 750,000,000 shares of DPLS
have been shorted
The DPLS Squeeze Trigger price of $0.01
is the volume weighted average price
that all shorts are short
in shares of DPLS
BuyIns.Net Alerts for Symbol DPLS
http://www.buyins.net/tools/symbol_stats.php?sym=DPLS
DPLS Short Report
https://otcshortreport.com/company/DPLS
_________________________________________________________________
Live! Charts
_________________________________________________________________
________________________________________________________________
Recent DPLS News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 03:56:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:25:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 07:14:41 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/18/2023 09:39:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 08:18:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 05:00:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/15/2023 10:16:05 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 05:55:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/14/2023 05:15:11 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 11/07/2023 09:29:36 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/20/2023 09:17:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 12:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 07:51:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/22/2023 08:41:26 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/31/2023 09:19:17 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:32:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 05:01:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:10:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 06:32:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/18/2023 09:16:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 08:05:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/06/2023 06:21:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM